Format: 1-hour Virtual Thought Leadership Session
Date & Time: Wednesday, 18th September, 1:30–2:30 PM BST / 8:30–9:30 AM EST
Platform: Zoom
1:30 PM – Thought Leader Interview (20 mins)
Title: Unlocking the Brain: Innovations in CNS Drug Discovery and Neurodegenerative Treatment
Interview with: Emma Mead, Chief Scientific Officer, Alzheimer's Research UK, Oxford Drug Discovery Institute
2:00 PM – Panel Discussion (30 mins)
Title: Innovative Approaches to CNS Drug Delivery and Neurodegenerative Therapeutics
Discussion Topics:
- How CNS shuttle technologies are revolutionising drug delivery across the blood-brain barrier
- Emerging therapeutic targets and translational strategies in Alzheimer’s and neurodegenerative disease
- Opportunities & challenges of academic-industry partnerships in advancing CNS drug discovery
Moderator:
Emma Mead, Chief Scientific Officer, Alzheimer's Research UK, Oxford Drug Discovery Institute
Panellists:
S Moein Moghimi, Professor of Nanomedicine and Pharmaceutics, School of Pharmacy, Newcastle University, UK
Shadi Farhangrazi, Chief Executive Officer, S. M. Discovery Group (SMDG
To attend this Thought Leadership session you need to be a Premium LifeScienceXchange member.
Secure all the benefits and sign-up for Premium membership now
*If you’re already a Premium member your exclusive invite will be sent direct to your inbox